VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 30, 2014) - Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or the "Company") is pleased to announce that John Plaza has agreed to join the Company's investee Agrisoma's Board of Directors as Calyx nominee effective January 20th, 2014. Mr. Plaza brings extensive biorefinery and executive leadership experience to Agrisoma.

John Plaza is president, CEO and founder of Imperium Renewables in Seattle, Washington. Mr. Plaza started the company in February 2004 by building the first commercial scale biodiesel production facility in the western United States. By 2007, Imperium developed, built and now currently operates Imperium Grays Harbor, one of the largest biodiesel production facilities in the world at 100 million gallons per year. The company's core focus was to develop and build advanced technology for biofuel production that differentiated itself in the market with fuel quality and scale. This innovative direction, which was led by Mr. Plaza, facilitated Imperium's significant growth. Most recently, Imperium has been focused on renewable jet fuel production platforms. These include building commercial scale facilities to produce renewable jet fuel, as well as research and development of future production pathways for renewable jet fuel from biomass sources. Prior to founding Imperium Renewables, Mr. Plaza was a commercial airline pilot for 20 years. John has flown over 17,000 hours in more that 50 different aircraft, starting his career as a bush pilot in Northern Alaska, then going on to fly B747, DC-10 and A-320 aircraft for Northwest Airlines. Mr. Plaza has acted as an Adviser to the Clinton Global Initiative Americas, 2012 Clean Fuel & Transportation and is a contributor to the Sustainable Alternative Fuels for Aviation Expert Group (SUSTAF) created by ICAO. He has been named one of the top 100 People in Bioenergy the last three years.

"I am excited to be a part of the team for this innovative company and greatly support their efforts to assist with the diversification of agricultural products for farmers throughout the world. The vision and opportunities for the supply of a non-food oilseed crop like Carinata is of critical importance for the future of renewable fuels. Biofuels produced from Carinata provide an important option to meeting the rapid growth in energy demand, while effectively balancing social and environmental needs," said John Plaza.

"We are delighted to have John sit as a Calyx nominee on the Agrisoma Board. John is a well-connected, big vision guy with industry-leading bioenergy knowledge and the track record to back it up. His experience in both aviation and biorefining are vital in the commercialization of carinata," commented Don Konantz, Chief Executive Officer of Calyx.

About Calyx

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company focused on renewable fuels including biojet and biodiesel. Calyx is the largest shareholder of Agrisoma Biosciences Inc., a company which is producing a new proprietary non-food energy feedstock crop - carinata - which yields oil that can be refined into fuels that work in existing engines as a 100 percent petroleum substitute. From seed to sky, fuels produced from carinata substantially reduce carbon and other harmful emissions, and help to reduce global petroleum dependence. Carinata was used to fly the world's first 100% biojet flight, as achievement that Popular Science called one of the top science events on the planet in 2012. For further information about Calyx, please visit For more information on Agrisoma, please visit

Forward-Looking Statements: This document contains certain forward-looking statements concerning Calyx, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, or performance that may constitute "forward-looking statements" or "forward-looking information" under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Calyx's control.

Such forward-looking statements or information are based on a number of assumptions, which may prove to be incorrect.

Although Calyx believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Calyx can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Calyx and described in the forward-looking statements or information.

The forward-looking statements or information contained in this news release are made as of the date hereof and Calyx undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the TSX Venture Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:

Calyx Bio-Ventures Inc.
Don Konantz
President & CEO

Calyx Bio-Ventures Inc.
Keir Reynolds
Investor Relations